PCDHGB7 and leukemia: Recently, Jonart and their colleagues found that disruption of the central nervous system leukemia niche with Me6 did not result in an increased leukemia burden in brain parenchyma, liver, kidney, bone marrow and spleen, indicating no significant effect caused by Me6 itself on leukemia cell proliferation 41.